A Safety and Dose Defining Study to Evaluate Intravenous Heme Arginate Infusion in Patients With an Acute Coronary Syndrome Without ST-Elevation (NSTEMI).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Haem arginate (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- Acronyms HAEM
Most Recent Events
- 20 Sep 2010 Biomarkers information updated
- 17 Sep 2010 Trial phase changed from II/III to I/II as reported by ClinicalTrials.gov.
- 16 Mar 2010 Actual initiation date (Feb 2010) and actual number of patients (45) added as reported by ClinicalTrials.gov.